文献速递前列腺癌

晚期前列腺癌背景下根治性前列腺切除术的围手术期结局

Peri-operative outcomes following radical prostatectomy in the setting of advanced prostate cancer.
PubMed 文献 · BJU Int · 2024-04-23

基于美国外科医师学会国家外科质量改进项目,回顾2019至2021年9276例根治性前列腺切除术,按病理分期比较局限期与局部晚期(T3-4)、淋巴结阳性(N+)、转移(M+)患者的30天围手术期结局;局部晚期、淋巴结阳性和转移患者行根治性前列腺切除术看似安全,30天死亡率或主要并发症未显著升高,但住院时间延长、部分并发症略增,原文指出需进一步研究。

要点

  • 局部晚期(T3-4)患者次要并发症略高,主要并发症、30天死亡率、再入院及直肠损伤无显著差异。
  • 淋巴结阳性(N+)与更长手术时间、更长住院时间及部分30天并发症率略增相关。
  • 转移(M+)患者行根治性前列腺切除术看似与M0患者同样安全,但住院时间更长、某些并发症率略增。

核心结论

  • 对于病理确定的局部晚期、淋巴结阳性和转移性前列腺癌患者,根治性前列腺切除术看似安全,与局限期前列腺癌相比,30天死亡率或主要并发症未显著升高。
  • 本研究为探讨根治性前列腺切除术在晚期前列腺癌中作用的文献增添了证据;原文指出需进一步研究以更好地描述此类患者手术的风险与获益。

研究设计与样本

  • 使用美国外科医师学会国家外科质量改进项目,识别2019至2021年间实施的根治性前列腺切除术。
  • 按病理分期分层,比较局部晚期(T3-4)、淋巴结阳性(N+)、转移(M+)与局限期前列腺癌(T1-2 N0 M0)的基线人口学特征和30天结局。
  • 比较的30天结局包括手术时间、住院时间、30天死亡率、再入院、再手术、主要并发症、次要并发症和手术特异性并发症。
  • 可获得病理分期数据的根治性前列腺切除术共9276例,基线人口学特征具有可比性。

主要发现

  • 局部晚期队列的次要并发症率略高,但主要并发症、30天死亡率、再入院或直肠损伤无显著差异。
  • 淋巴结阳性与更长手术时间、更长住院时间以及部分30天并发症率略增相关。
  • 转移性疾病患者行根治性前列腺切除术看似与M0疾病患者同样安全,但住院时间更长,某些并发症率略增。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出,需进一步研究以更好地描述此类患者手术的风险与获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the peri-operative outcomes of radical prostatectomy (RP) for locally advanced, node-positive, and metastatic prostate cancer (PCa), as determined through pathological staging, using the American College of Surgeons National Surgical Quality Improvement Project. METHODS: We identified RP procedures performed between 2019 and 2021. Patients were stratified by pathological staging to compare the effect of locally advanced disease (T3-4), node positivity (N+) and metastasis (M+) vs localised PCa (T1-2 N0 M0). Baseline demographics and 30-day outcomes, including operating time, length of hospital stay (LOS), 30-day mortality, readmissions, reoperations, major complications, minor complications and surgery-specific complications, were compared between groups. RESULTS: Pathological staging data were available for 9276 RPs. Baseline demographics were comparable. There was a slightly higher rate of minor complications in the locally advanced cohort, but no significant difference in major complications, 30-day mortality, readmissions, or rectal injuries. Node positivity was associated with longer operating time, LOS, and some slightly increased rates of 30-day complications. RP in patients with metastatic disease appeared to be similarly safe to RP in patients with M0 disease, although it was associated with a longer LOS and slightly increased rates of certain complications. CONCLUSIONS: For patients with pathologically determined locally advanced, node-positive, and metastatic PCa, RP appears to be safe, and is not associated with significantly higher rates of 30-day mortality or major complications compared to RP for localised PCa. This study adds to the growing body of literature investigating the role of RP for advanced PCa; further studies are needed to better characterise the risks and benefits of surgery in such patients.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Simhal RK, Wang KR, Shah YB, et al. Peri-operative outcomes following radical prostatectomy in the setting of advanced prostate cancer. BJU Int. 2024. PMID: 38653516. doi:10.1111/bju.16370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。